Status:

COMPLETED

Development of a Metabolic Assessment Tool for Chronic Kidney Disease

Lead Sponsor:

University of California, Davis

Conditions:

Immunoglobulin A Nephropathy

Healthy Subjects

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The purpose of this study is to examine the variation between individuals in blood lipid metabolites, and the changes in these metabolites in response to omega-3 fatty acids in patients with immunoglo...

Detailed Description

It is unclear how metabolomic profiles of individuals change in response to short-term intervention with omega-3 fatty acids. It is necessary to establish the means and standard deviations in the leve...

Eligibility Criteria

Inclusion

  • Weight at least 110 pounds or BMI at least 19
  • Adult (aged 18-65 years old)
  • Disclose which medications currently taking
  • Able to come to the Ragle Center at the designated times
  • Able to give blood
  • Able to take 6 g fish oil per day for 6 weeks
  • Able to carry out first morning urine collection
  • Able to stop or avoid taking NSAIDS and allergy medications for 6 weeks
  • Able to stop or avoid eating seafood and seaweed for 6 weeks

Exclusion

  • Pregnant or nursing (or unsure if pregnant)
  • Diagnosed with a disease by their physician
  • Currently taking prescription medications that alter lipid metabolism (such as HMG CoA reductase inhibitors, PPAR agonists, steroids) and/or anti-coagulants
  • Currently has some form of anemia (or unsure)
  • Has an existing health condition or concern
  • Unable to stop or avoid taking NSAIDS and allergy medications for 6 weeks
  • Unable to stop or avoid eating seafood or seaweed for 6 weeks
  • Unable to give blood or do first morning urine collection
  • Recently recovering from a major injury, infection, or illness (in the last 2-4 weeks)

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT01838239

Start Date

June 1 2008

End Date

June 1 2011

Last Update

May 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California Davis

Davis, California, United States, 95616

Development of a Metabolic Assessment Tool for Chronic Kidney Disease | DecenTrialz